{
  "name": "Episode 1",
  "headline": "Immune Checkpoint Inhibitors have been transformative for cancer care. What have we learnt so far?\nHosts: \nDr. Afreen Shariff, MD, Endocrinologist, Duke Cancer Institute; \nDr. Tian Zhang, MD, MHS, Genito-Urinary Oncologist, Duke Cancer Institute",
  "link_spotify": "http://www.freebsddiary.org/APC/usb_hid_usages.php",
  "link_apple": "http://www.freebsddiary.org/APC/usb_hid_usages.php"
}